CMM10
MCID: MLN055
MIFTS: 52

Melanoma, Cutaneous Malignant 10 (CMM10)

Categories: Cancer diseases, Genetic diseases, Nephrological diseases, Rare diseases, Skin diseases

Aliases & Classifications for Melanoma, Cutaneous Malignant 10

MalaCards integrated aliases for Melanoma, Cutaneous Malignant 10:

Name: Melanoma, Cutaneous Malignant 10 56 73
Melanoma, Cutaneous Malignant, Susceptibility to, 10 56 29 6
Cmm10 56 73
Melanoma, Cutaneous, Malignant, Susceptibility to, Type 10 39
Melanoma 43

Characteristics:

OMIM:

56
Miscellaneous:
adult onset
incomplete penetrance

Inheritance:
autosomal dominant


HPO:

31
melanoma, cutaneous malignant 10:
Inheritance autosomal dominant inheritance
Onset and clinical course adult onset incomplete penetrance


Classifications:



External Ids:

OMIM 56 615848
OMIM Phenotypic Series 56 PS155600
MeSH 43 D008545
SNOMED-CT via HPO 68 2092003 263681008 372244006

Summaries for Melanoma, Cutaneous Malignant 10

UniProtKB/Swiss-Prot : 73 Melanoma, cutaneous malignant 10: A malignant neoplasm of melanocytes, arising de novo or from a pre- existing benign nevus, which occurs most often in the skin but also may involve other sites.

MalaCards based summary : Melanoma, Cutaneous Malignant 10, also known as melanoma, cutaneous malignant, susceptibility to, 10, is related to melanoma and melanoma, cutaneous malignant 1. An important gene associated with Melanoma, Cutaneous Malignant 10 is POT1 (Protection Of Telomeres 1). The drugs Vindesine and Pravastatin have been mentioned in the context of this disorder. Affiliated tissues include skin, lymph node and brain, and related phenotype is melanoma.

More information from OMIM: 615848 PS155600

Related Diseases for Melanoma, Cutaneous Malignant 10

Diseases in the Melanoma, Cutaneous Malignant 1 family:

Melanoma, Cutaneous Malignant 2 Melanoma, Cutaneous Malignant 4
Melanoma, Cutaneous Malignant 3 Melanoma, Cutaneous Malignant 7
Melanoma, Cutaneous Malignant 5 Melanoma, Cutaneous Malignant 6
Melanoma, Cutaneous Malignant 8 Melanoma, Cutaneous Malignant 9
Melanoma, Cutaneous Malignant 10

Diseases related to Melanoma, Cutaneous Malignant 10 via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1877, show less)
# Related Disease Score Top Affiliating Genes
1 melanoma 13.0
2 melanoma, cutaneous malignant 1 12.8
3 melanoma, uveal 12.7
4 ocular melanoma 12.7
5 acral lentiginous melanoma 12.7
6 skin melanoma 12.7
7 melanoma-astrocytoma syndrome 12.6
8 nodular malignant melanoma 12.6
9 melanoma-pancreatic cancer syndrome 12.6
10 mucosal melanoma 12.6
11 melanoma, cutaneous malignant 8 12.6
12 digestive system melanoma 12.6
13 melanoma, cutaneous malignant 2 12.6
14 melanoma, cutaneous malignant 3 12.6
15 melanoma, cutaneous malignant 5 12.6
16 melanoma, cutaneous malignant 9 12.6
17 melanoma, cutaneous malignant 6 12.6
18 amelanotic melanoma 12.6
19 primary melanoma of the central nervous system 12.5
20 malignant spindle cell melanoma 12.5
21 superficial spreading melanoma 12.5
22 melanoma-associated retinopathy 12.5
23 melanoma, cutaneous malignant 4 12.5
24 melanoma, cutaneous malignant 7 12.5
25 lentigo maligna melanoma 12.4
26 melanoma in congenital melanocytic nevus 12.4
27 necrotic uveal melanoma 12.4
28 spitzoid melanoma 12.4
29 dysplastic nevus syndrome 12.3
30 malignant conjunctival melanoma 12.3
31 choroid spindle cell melanoma 12.3
32 iris spindle cell melanoma 12.3
33 hereditary melanoma 12.3
34 posterior uveal melanoma 12.3
35 mixed cell uveal melanoma 12.3
36 malignant anus melanoma 12.3
37 malignant choroid melanoma 12.3
38 esophagus melanoma 12.3
39 malignant iris melanoma 12.3
40 vulvar melanoma 12.3
41 malignant breast melanoma 12.3
42 meningeal melanoma 12.2
43 malignant ciliary body melanoma 12.2
44 spinal cord melanoma 12.2
45 epithelioid cell melanoma 12.2
46 gallbladder melanoma 12.2
47 malignant cornea melanoma 12.2
48 melanoma, uveal 2 12.2
49 melanoma, uveal 1 12.2
50 retinal melanoma 12.2
51 primary malignant melanoma of the cervix 12.2
52 balloon cell malignant melanoma 12.2
53 rectum malignant melanoma 12.2
54 melanoma tumor antigen gp90 12.2
55 spindle cell intraocular melanoma 12.2
56 ovarian melanoma 12.2
57 malignant eyelid melanoma 12.2
58 scrotum melanoma 12.2
59 skin carcinoma 12.1
60 bap1 tumor predisposition syndrome 12.1
61 malignant melanoma of the mucosa 12.1
62 melanoma of soft tissue 12.1
63 melanoma, malignant familial intraocular 12.1
64 cervix melanoma 12.1
65 primary malignant melanoma of the conjunctiva 12.1
66 skin amelanotic melanoma 12.1
67 choroid mixed cell melanoma 12.1
68 ciliary body spindle cell melanoma 12.1
69 adult leptomeningeal melanoma 12.1
70 uveal epithelioid cell melanoma 12.1
71 choroid epithelioid cell melanoma 12.1
72 choroid necrotic melanoma 12.1
73 pediatric leptomeningeal melanoma 12.0
74 intermediate cell type ciliary body melanoma 12.0
75 ciliary body epithelioid cell melanoma 12.0
76 ciliary body mixed cell melanoma 12.0
77 iris mixed cell melanoma 12.0
78 cdk4 linked melanoma 12.0
79 malignant melanoma, childhood 12.0
80 tièche-jadassohn nevus 11.9
81 large congenital melanocytic nevus 11.7
82 melanosis, neurocutaneous 11.7
83 tumor predisposition syndrome 11.7
84 melanocytic nevus syndrome, congenital 11.7
85 malignant skin fibrous histiocytoma 11.6
86 clear cell sarcoma 11.6
87 epidermodysplasia verruciformis 1 11.5
88 autoimmune retinopathy 11.5
89 spitz nevus 11.5
90 skin/hair/eye pigmentation, variation in, 3 11.5
91 retinoblastoma 11.5
92 squamous cell carcinoma 11.5
93 albinism, oculocutaneous, type ii 11.4
94 oculocutaneous albinism 11.4
95 ocular cancer 11.4
96 malignant fibrous histiocytoma 11.4
97 glioma susceptibility 1 11.4
98 squamous cell carcinoma, head and neck 11.4
99 cowden syndrome 11.4
100 basal cell nevus syndrome 11.4
101 xeroderma pigmentosum, complementation group c 11.4
102 clear cell acanthoma 11.4
103 nevus, epidermal 11.4
104 papillon-lefevre syndrome 11.4
105 albinism, oculocutaneous, type ib 11.4
106 singleton-merten syndrome 11.4
107 pancreatic cancer 5 11.1
108 penis carcinoma in situ 11.1
109 radiation induced cancer 11.1
110 merkel cell carcinoma 11.0
111 neuroblastoma 11.0
112 lung cancer 11.0
113 lentigines 10.9
114 multiple self-healing squamous epithelioma 10.8
115 basal cell carcinoma 10.8
116 polycystic kidney disease 10.8
117 microphthalmia 10.8
118 ulcerative colitis 10.7
119 paget disease, extramammary 10.7
120 vitiligo-associated multiple autoimmune disease susceptibility 6 10.7
121 vitiligo-associated multiple autoimmune disease susceptibility 1 10.7
122 retinal detachment 10.7
123 follicular lymphoma 10.7
124 crohn's disease 10.7
125 sebaceous adenocarcinoma 10.7
126 rare tumor 10.7
127 keratosis 10.7
128 severe combined immunodeficiency 10.7
129 sweat gland cancer 10.6
130 neutropenia 10.6
131 renal cell carcinoma, nonpapillary 10.6
132 exanthem 10.6
133 breast cancer 10.6
134 familial retinoblastoma 10.5
135 neovascular glaucoma 10.5
136 cytokine deficiency 10.5
137 dowling-degos disease 1 10.5
138 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.5
139 sarcoma 10.5
140 vaccinia 10.5
141 actinic keratosis 10.5
142 spindle cell sarcoma 10.5
143 47,xyy 10.5
144 skin disease 10.5
145 pancreatic cancer 10.5
146 xeroderma pigmentosum, variant type 10.5
147 uveitis 10.5
148 colorectal cancer 10.5
149 dermatomyositis 10.4
150 autoimmune disease 10.4
151 pilomatrix carcinoma 10.4
152 adenocarcinoma 10.4
153 dysphagia 10.4
154 neurofibromatosis 10.4
155 optic nerve disease 10.4
156 bowen's disease 10.4
157 intussusception 10.4
158 alopecia 10.4
159 hereditary lymphedema i 10.4
160 hypoxia 10.4
161 fibrosarcoma 10.4
162 thyroid carcinoma 10.4
163 glioma 10.4
164 lymphoma 10.4
165 cataract 10.4
166 48,xyyy 10.4
167 soft tissue sarcoma 10.4
168 diarrhea 10.4
169 b-cell lymphoma 10.4
170 glioblastoma multiforme 10.4
171 glial tumor 10.4
172 yemenite deaf-blind hypopigmentation syndrome 10.4
173 intraocular pressure quantitative trait locus 10.4
174 kidney cancer 10.4
175 thrombocytopenia 10.4
176 hemangioma 10.4
177 leukemia 10.4
178 inverted follicular keratosis 10.4
179 keratosis, seborrheic 10.3
180 neurilemmoma 10.3
181 pustulosis of palm and sole 10.3
182 psoriasis 10.3
183 sarcoidosis 1 10.3
184 lymphopenia 10.3
185 allergic hypersensitivity disease 10.3
186 teratoma 10.3
187 hypothyroidism 10.3
188 cystic teratoma 10.3
189 dermatitis 10.3
190 neurofibroma 10.3
191 posttransplant acute limbic encephalitis 10.3
192 macular retinal edema 10.3
193 exophthalmos 10.3
194 meningioma, radiation-induced 10.3
195 meningioma, familial 10.3
196 spinal meningioma 10.3
197 mammary paget's disease 10.3
198 secretory meningioma 10.3
199 lymphoplasmacyte-rich meningioma 10.3
200 herpes simplex 10.3
201 ovarian cancer 10.3
202 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.3
203 interstitial lung disease 10.3
204 keratoacanthoma 10.3
205 neuropathy 10.3
206 prostate cancer 10.3
207 hemorrhoid 10.3
208 lymphoma, hodgkin, classic 10.3
209 osteogenic sarcoma 10.3
210 lung disease 10.3
211 nevus of ota 10.3
212 kaposi sarcoma 10.3
213 albinism 10.3
214 astrocytoma 10.3
215 adenoma 10.3
216 stomatitis 10.3
217 rapidly involuting congenital hemangioma 10.3
218 benign mesothelioma 10.3
219 ataxia and polyneuropathy, adult-onset 10.2
220 pertussis 10.2
221 telangiectasis 10.2
222 chudley-mccullough syndrome 10.2
223 night blindness 10.2
224 melioidosis 10.2
225 tongue squamous cell carcinoma 10.2
226 alcoholic hepatitis 10.2
227 chronic interstitial cystitis 10.2
228 hepatosplenic t-cell lymphoma 10.2
229 tetanus 10.2
230 papilloma 10.2
231 hepatocellular carcinoma 10.2
232 seizures, scoliosis, and macrocephaly/microcephaly syndrome 10.2
233 constipation 10.2
234 leukemia, chronic lymphocytic 10.2
235 thyroiditis 10.2
236 bladder cancer 10.2
237 alstrom syndrome 10.2
238 lymphoma, non-hodgkin, familial 10.2
239 intestinal obstruction 10.2
240 lymph node disease 10.2
241 squamous cell papilloma 10.2
242 iridocyclitis 10.2
243 leiomyosarcoma 10.2
244 body mass index quantitative trait locus 1 10.2
245 gastrointestinal stromal tumor 10.2
246 helix syndrome 10.2
247 urticaria 10.2
248 cholecystitis 10.2
249 malignant peripheral nerve sheath tumor 10.2
250 parkinson disease, late-onset 10.2
251 ataxia-telangiectasia 10.2
252 respiratory failure 10.2
253 cholera 10.2
254 pigmented basal cell carcinoma 10.2
255 cutaneous fibrous histiocytoma 10.2
256 peripheral nervous system disease 10.2
257 pulmonary embolism 10.2
258 pyogenic granuloma 10.2
259 small cell cancer of the lung 10.2
260 thyroid cancer, nonmedullary, 1 10.2
261 mucositis 10.2
262 halo nevi 10.2
263 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.2
264 angiosarcoma 10.2
265 colitis 10.2
266 colon adenocarcinoma 10.2
267 newcastle disease 10.2
268 rhabdomyosarcoma 10.2
269 macular degeneration, age-related, 1 10.1
270 ptosis 10.1
271 diphtheria 10.1
272 cellulitis 10.1
273 myeloid leukemia 10.1
274 esophageal cancer 10.1
275 lung cancer susceptibility 3 10.1
276 gastric cancer 10.1
277 hydrocephalus 10.1
278 obstructive jaundice 10.1
279 mature teratoma 10.1
280 chromosomal triplication 10.1
281 myositis 10.1
282 inflammatory bowel disease 10.1
283 skin benign neoplasm 10.1
284 in situ carcinoma 10.1
285 neurofibromatosis, type ii 10.1
286 deficiency anemia 10.1
287 scleritis 10.1
288 panniculitis 10.1
289 impotence 10.1
290 fibrous histiocytoma 10.1
291 bullous pemphigoid 10.1
292 hypereosinophilic syndrome 10.1
293 rheumatoid arthritis 10.1
294 testicular cancer 10.1
295 breast adenocarcinoma 10.1
296 myocarditis 10.1
297 cancer-associated retinopathy 10.1
298 thrombophilia due to thrombin defect 10.1
299 triiodothyronine receptor auxiliary protein 10.1
300 myasthenia gravis 10.1
301 insulin-like growth factor i 10.1
302 dermatofibrosarcoma protuberans 10.1
303 leukemia, acute lymphoblastic 10.1
304 variola major 10.1
305 benign teratoma 10.1
306 hemopericardium 10.1
307 pericardial effusion 10.1
308 ovarian cystic teratoma 10.1
309 hyperthyroidism 10.1
310 vasculitis 10.1
311 smallpox 10.1
312 erythrokeratoderma ''en cocardes'' 10.1
313 granulocytopenia 10.1
314 splenomegaly 10.1
315 lichen sclerosus et atrophicus 10.1
316 endometrial cancer 10.1
317 oral squamous cell carcinoma 10.1
318 cutaneous t cell lymphoma 10.1
319 myopathy 10.1
320 halo nevus 10.1
321 argyria 10.1
322 wilms tumor 5 10.1
323 leukemia, acute myeloid 10.1
324 ewing sarcoma 10.1
325 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.1
326 retinal vascular disease 10.1
327 pik3ca-related overgrowth syndrome 10.1
328 mesothelioma, malignant 10.1
329 congenital heart defects, hamartomas of tongue, and polysyndactyly 10.1
330 mycosis fungoides 10.1
331 sarcoma, synovial 10.1
332 secondary progressive multiple sclerosis 10.1
333 panuveitis 10.1
334 polyneuropathy 10.1
335 superficial basal cell carcinoma 10.1
336 melanomatosis 10.1
337 ileus 10.1
338 lichen planus 10.1
339 back pain 10.1
340 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.0
341 dermatitis, atopic 10.0
342 covid-19 10.0
343 rickets 10.0
344 palmoplantar keratosis 10.0
345 endophthalmitis 10.0
346 eye disease 10.0
347 dermatophytosis 10.0
348 meningitis 10.0
349 headache 10.0
350 paraneoplastic syndromes 10.0
351 suppressor of tumorigenicity 3 10.0
352 myeloma, multiple 10.0
353 proteasome-associated autoinflammatory syndrome 1 10.0
354 cervical cancer 10.0
355 leukemia, chronic myeloid 10.0
356 hypophosphatemia 10.0
357 leiomyoma 10.0
358 iron metabolism disease 10.0
359 teratocarcinoma 10.0
360 histiocytosis 10.0
361 hyperglycemia 10.0
362 enterocolitis 10.0
363 abcd syndrome 10.0
364 nasopharyngeal carcinoma 10.0
365 microvascular complications of diabetes 5 10.0
366 myelodysplastic syndrome 10.0
367 pachyonychia congenita 3 10.0
368 small cell carcinoma 10.0
369 disseminated intravascular coagulation 10.0
370 vogt-koyanagi-harada disease 10.0
371 acute leukemia 10.0
372 rubeosis iridis 10.0
373 neuroma 10.0
374 bilirubin metabolic disorder 10.0
375 malignant glioma 10.0
376 purpura 10.0
377 lymphosarcoma 10.0
378 paresthesia 10.0
379 multiple sclerosis 10.0
380 li-fraumeni syndrome 10.0
381 neurofibromatosis, type i 10.0
382 thymoma, familial 10.0
383 anxiety 10.0
384 autosomal recessive disease 10.0
385 plica syndrome 10.0
386 retinal vein occlusion 10.0
387 synovitis 10.0
388 thymoma 10.0
389 liposarcoma 10.0
390 pancreatic ductal adenocarcinoma 10.0
391 lymphocele 10.0
392 peritonitis 10.0
393 influenza 10.0
394 arthritis 10.0
395 stevens-johnson syndrome/toxic epidermal necrolysis 10.0
396 polyploidy 10.0
397 keratitis, hereditary 10.0
398 li-fraumeni syndrome 2 10.0
399 graft-versus-host disease 10.0
400 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 10.0
401 erythema multiforme 10.0
402 corneal edema 10.0
403 chorioretinal scar 10.0
404 brain cancer 10.0
405 keratopathy 10.0
406 endometriosis 10.0
407 multiple endocrine neoplasia 10.0
408 angiomyolipoma 10.0
409 vaginal discharge 10.0
410 spindle cell carcinoma 10.0
411 systemic scleroderma 10.0
412 pneumonia 10.0
413 paraplegia 10.0
414 herpes zoster 10.0
415 ocular hypertension 10.0
416 polymyositis 10.0
417 acute liver failure 10.0
418 branchiootic syndrome 1 10.0
419 peripheral vascular disease 10.0
420 female breast cancer 10.0
421 thrombosis 10.0
422 bone resorption disease 10.0
423 orbital cellulitis 10.0
424 sympathetic ophthalmia 10.0
425 iritis 10.0
426 ectropion 10.0
427 vascular disease 10.0
428 neuroendocrine carcinoma 10.0
429 acute kidney failure 10.0
430 ischemia 10.0
431 pancreatic adenocarcinoma 10.0
432 connective tissue disease 10.0
433 compartment syndrome 10.0
434 meningeal melanomatosis 10.0
435 measles 10.0
436 lupus erythematosus 10.0
437 intracranial hypertension 10.0
438 oral cancer 10.0
439 encephalopathy 10.0
440 amyotrophic lateral sclerosis 1 9.9
441 erythroleukemia, familial 9.9
442 ige responsiveness, atopic 9.9
443 pheochromocytoma 9.9
444 chondrosarcoma 9.9
445 immune deficiency disease 9.9
446 body mass index quantitative trait locus 11 9.9
447 body mass index quantitative trait locus 9 9.9
448 body mass index quantitative trait locus 8 9.9
449 body mass index quantitative trait locus 4 9.9
450 body mass index quantitative trait locus 10 9.9
451 body mass index quantitative trait locus 7 9.9
452 body mass index quantitative trait locus 12 9.9
453 body mass index quantitative trait locus 14 9.9
454 body mass index quantitative trait locus 18 9.9
455 leukemia, acute lymphoblastic 3 9.9
456 body mass index quantitative trait locus 19 9.9
457 body mass index quantitative trait locus 20 9.9
458 colorectal adenocarcinoma 9.9
459 adrenal gland pheochromocytoma 9.9
460 pigmentation disease 9.9
461 conjunctival pigmentation 9.9
462 paronychia 9.9
463 skin sarcoidosis 9.9
464 panophthalmitis 9.9
465 neuritis 9.9
466 rectum cancer 9.9
467 intestinal perforation 9.9
468 hepatitis 9.9
469 lateral sclerosis 9.9
470 glomerulonephritis 9.9
471 mastocytosis 9.9
472 olfactory neuroblastoma 9.9
473 plasmacytoma 9.9
474 angiokeratoma 9.9
475 liver cirrhosis 9.9
476 meningeal melanocytoma 9.9
477 congestive heart failure 9.9
478 epithelioid sarcoma 9.9
479 anthrax disease 9.9
480 active peptic ulcer disease 9.9
481 alopecia areata 9.9
482 keloid disorder 9.9
483 carcinoma showing thymus-like differentiation 9.9
484 differentiated thyroid carcinoma 9.9
485 hashimoto thyroiditis 9.9
486 hypercholesterolemia, familial, 1 9.9
487 hypertriglyceridemia, familial 9.9
488 systemic lupus erythematosus 9.9
489 polykaryocytosis inducer 9.9
490 factor vii deficiency 9.9
491 testicular germ cell tumor 9.9
492 human immunodeficiency virus type 1 9.9
493 diabetes mellitus, ketosis-prone 9.9
494 familial adenomatous polyposis 9.9
495 bone disease 9.9
496 neuroretinitis 9.9
497 interstitial nephritis 9.9
498 cardiac tamponade 9.9
499 melanoacanthoma 9.9
500 iron deficiency anemia 9.9
501 blind hypotensive eye 9.9
502 lymphocytic choriomeningitis 9.9
503 pancytopenia 9.9
504 guillain-barre syndrome 9.9
505 acute closed-angle glaucoma 9.9
506 capillary leak syndrome 9.9
507 lymphangioma 9.9
508 benign ependymoma 9.9
509 chronic inflammatory demyelinating polyradiculoneuropathy 9.9
510 demyelinating polyneuropathy 9.9
511 cellular ependymoma 9.9
512 chickenpox 9.9
513 pemphigus 9.9
514 fasciitis 9.9
515 tetraploidy 9.9
516 limbal stem cell deficiency 9.9
517 rare lymphatic malformation 9.9
518 erythema multiforme major 9.9
519 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.9
520 overgrowth syndrome 9.9
521 scleroderma, familial progressive 9.9
522 strabismus 9.9
523 temporal arteritis 9.9
524 kearns-sayre syndrome 9.9
525 langerhans cell histiocytosis 9.9
526 anaplastic large cell lymphoma 9.9
527 fibroma 9.9
528 cholelithiasis 9.9
529 open-angle glaucoma 9.9
530 optic neuritis 9.9
531 hyperparathyroidism 9.9
532 cholestasis 9.9
533 posterior scleritis 9.9
534 facial paralysis 9.9
535 retinal vascular occlusion 9.9
536 autoimmune hepatitis 9.9
537 thrombocytosis 9.9
538 contact dermatitis 9.9
539 cervix carcinoma 9.9
540 acute pancreatitis 9.9
541 skin squamous cell carcinoma 9.9
542 breast disease 9.9
543 retinitis 9.9
544 carcinosarcoma 9.9
545 clear cell renal cell carcinoma 9.9
546 eccrine acrospiroma 9.9
547 hemolytic anemia 9.9
548 conjunctivitis 9.9
549 cll/sll 9.9
550 nervous system disease 9.9
551 mechanical strabismus 9.9
552 scotoma 9.9
553 hypopituitarism 9.9
554 encephalitis 9.9
555 myotonic dystrophy 9.9
556 trichorhinophalangeal syndrome 9.9
557 central serous chorioretinopathy 9.9
558 embryonal sarcoma 9.9
559 cerebrofacial arteriovenous metameric syndrome 9.9
560 burkitt lymphoma 9.8
561 coloboma of macula 9.8
562 birt-hogg-dube syndrome 9.8
563 leiomyoma, uterine 9.8
564 mastocytosis, cutaneous 9.8
565 peutz-jeghers syndrome 9.8
566 thrombocytopenic purpura, autoimmune 9.8
567 wilms tumor 1 9.8
568 mal de meleda 9.8
569 3-methylglutaconic aciduria, type iii 9.8
570 werner syndrome 9.8
571 xeroderma pigmentosum, complementation group d 9.8
572 retinoschisis 1, x-linked, juvenile 9.8
573 light fixation seizure syndrome 9.8
574 severe cutaneous adverse reaction 9.8
575 hepatitis c virus 9.8
576 b-cell expansion with nfkb and t-cell anergy 9.8
577 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.8
578 sleep apnea 9.8
579 lymphoproliferative syndrome 9.8
580 adenoid cystic carcinoma 9.8
581 dry eye syndrome 9.8
582 mumps 9.8
583 pulmonary edema 9.8
584 retinal vasculitis 9.8
585 nephrotic syndrome 9.8
586 retinal ischemia 9.8
587 plantar wart 9.8
588 toxic shock syndrome 9.8
589 pneumothorax 9.8
590 neuroendocrine tumor 9.8
591 thyroid gland cancer 9.8
592 pericarditis 9.8
593 hepatitis c 9.8
594 central retinal vein occlusion 9.8
595 transitional cell carcinoma 9.8
596 tic disorder 9.8
597 central nervous system disease 9.8
598 mesenchymal cell neoplasm 9.8
599 choriocarcinoma 9.8
600 gastric adenocarcinoma 9.8
601 pituitary adenoma 9.8
602 lynch syndrome 9.8
603 nodular basal cell carcinoma 9.8
604 radiculopathy 9.8
605 granulomatous dermatitis 9.8
606 acneiform dermatitis 9.8
607 bilateral retinoblastoma 9.8
608 pancreatitis 9.8
609 lung oat cell carcinoma 9.8
610 sarcomatoid squamous cell skin carcinoma 9.8
611 macular holes 9.8
612 muscular atrophy 9.8
613 end stage renal disease 9.8
614 tinea nigra 9.8
615 orbital disease 9.8
616 hypoglycemia 9.8
617 dentinogenesis imperfecta type 2 9.8
618 fibromatosis 9.8
619 chronic pain 9.8
620 myoclonus 9.8
621 syncope 9.8
622 diffuse leptomeningeal melanocytosis 9.8
623 multiple endocrine neoplasia, type i 9.8
624 hair whorl 9.8
625 lipomatosis, multiple 9.8
626 medulloblastoma 9.8
627 teratoma, ovarian 9.8
628 pemphigus vulgaris, familial 9.8
629 trigeminal neuralgia 9.8
630 anemia, autoimmune hemolytic 9.8
631 fanconi anemia, complementation group d2 9.8
632 ocular motor apraxia 9.8
633 graves disease 1 9.8
634 taqi polymorphism 9.8
635 retinitis pigmentosa 11 9.8
636 suppression of tumorigenicity 12 9.8
637 coronary heart disease 1 9.8
638 psoriatic arthritis 9.8
639 neutrophilic dermatosis, acute febrile 9.8
640 aplastic anemia 9.8
641 rhabdoid tumor predisposition syndrome 1 9.8
642 acute promyelocytic leukemia 9.8
643 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.8
644 cholangiocarcinoma 9.8
645 congenital stationary night blindness 9.8
646 atrioventricular block 9.8
647 conjunctival nevus 9.8
648 aphasia 9.8
649 cardiac arrest 9.8
650 rasopathy 9.8
651 sensorineural hearing loss 9.8
652 optic papillitis 9.8
653 pleomorphic lipoma 9.8
654 hydronephrosis 9.8
655 enophthalmos 9.8
656 primary hyperparathyroidism 9.8
657 vulva cancer 9.8
658 retinal perforation 9.8
659 gout 9.8
660 noonan syndrome with multiple lentigines 9.8
661 lymphadenitis 9.8
662 cheilitis 9.8
663 bone cancer 9.8
664 rectum adenocarcinoma 9.8
665 relapsing-remitting multiple sclerosis 9.8
666 epidermolysis bullosa 9.8
667 papillary carcinoma 9.8
668 pleomorphic rhabdomyosarcoma 9.8
669 systemic mastocytosis 9.8
670 mast cell neoplasm 9.8
671 rhabdoid cancer 9.8
672 pulmonary fibrosis 9.8
673 thrombophlebitis 9.8
674 gastritis 9.8
675 pyoderma 9.8
676 seminoma 9.8
677 pleomorphic adenoma 9.8
678 extracutaneous mastocytoma 9.8
679 embryoma 9.8
680 intrahepatic cholangiocarcinoma 9.8
681 ovarian germ cell teratoma 9.8
682 kidney disease 9.8
683 acquired immunodeficiency syndrome 9.8
684 appendicitis 9.8
685 localized scleroderma 9.8
686 pyoderma gangrenosum 9.8
687 molluscum contagiosum 9.8
688 chorioretinitis 9.8
689 diabetes mellitus 9.8
690 dacryoadenitis 9.8
691 dacryocystitis 9.8
692 toxoplasmosis 9.8
693 cataract-glaucoma 9.8
694 lymphocytic hypophysitis 9.8
695 ovarian epithelial cancer 9.8
696 phacomatosis pigmentovascularis 9.8
697 aneurysm 9.8
698 virus-associated trichodysplasia spinulosa 9.8
699 primary hypophysitis 9.8
700 red cell aplasia 9.8
701 acth deficiency, isolated 9.8
702 hemangiopericytoma, malignant 9.8
703 leprosy 3 9.8
704 pituitary hormone deficiency, combined, 2 9.8
705 reticulum cell sarcoma 9.8
706 xeroderma pigmentosum, complementation group a 9.8
707 arts syndrome 9.8
708 basal cell carcinoma 1 9.8
709 myocardial infarction 9.8
710 carney complex variant 9.8
711 hemophagocytic lymphohistiocytosis 9.8
712 multinodular goiter 9.8
713 diffuse large b-cell lymphoma 9.8
714 mantle cell lymphoma 9.8
715 paraganglioma 9.8
716 endocarditis 9.8
717 bacterial infectious disease 9.8
718 thrombotic thrombocytopenic purpura 9.8
719 bullous keratopathy 9.8
720 horner's syndrome 9.8
721 aseptic meningitis 9.8
722 goiter 9.8
723 bronchopneumonia 9.8
724 hepatitis a 9.8
725 acoustic neuroma 9.8
726 pure red-cell aplasia 9.8
727 tuberous sclerosis 9.8
728 obstructive hydrocephalus 9.8
729 papilledema 9.8
730 thrombocytopenia due to platelet alloimmunization 9.8
731 ichthyosis 9.8
732 acanthoma 9.8
733 vascular cancer 9.8
734 viral hepatitis 9.8
735 enthesopathy 9.8
736 ectodermal dysplasia 9.8
737 granulomatous hepatitis 9.8
738 sensory peripheral neuropathy 9.8
739 perivascular epithelioid cell tumor 9.8
740 lymphangiosarcoma 9.8
741 hairy cell leukemia 9.8
742 severe acute respiratory syndrome 9.8
743 pulmonary tuberculosis 9.8
744 antiphospholipid syndrome 9.8
745 mucinous adenocarcinoma 9.8
746 myelitis 9.8
747 mood disorder 9.8
748 porokeratosis 9.8
749 folliculitis 9.8
750 juvenile xanthogranuloma 9.8
751 infertility 9.8
752 epulis 9.8
753 optic nerve sheath meningioma 9.8
754 bronchitis 9.8
755 thyroid hyalinizing trabecular adenoma 9.8
756 lung lymphoma 9.8
757 eccrine porocarcinoma 9.8
758 parathyroid adenoma 9.8
759 interdigitating dendritic cell sarcoma 9.8
760 seborrheic dermatitis 9.8
761 rosacea 9.8
762 keratoconjunctivitis 9.8
763 diabetes insipidus 9.8
764 cholangitis 9.8
765 chronic dacryocystitis 9.8
766 germ cells tumors 9.8
767 grover's disease 9.8
768 hansen's disease 9.8
769 iridocorneal endothelial syndrome 9.8
770 neural crest tumor 9.8
771 pure autonomic failure 9.8
772 raynaud phenomenon 9.8
773 anoxia 9.8
774 cytomegalovirus infection 9.8
775 spinal cord injury 9.8
776 tremor 9.8
777 ring chromosome 9.8
778 hereditary palmoplantar keratoderma 9.8
779 acanthosis nigricans 9.7
780 atrial standstill 1 9.7
781 cardiac conduction defect 9.7
782 epidermoid cysts 9.7
783 pilomatrixoma 9.7
784 glaucoma, primary open angle 9.7
785 hypercalcemia, infantile, 1 9.7
786 meckel diverticulum 9.7
787 thyroid carcinoma, familial medullary 9.7
788 otitis media 9.7
789 papillomatosis, confluent and reticulated 9.7
790 benign chronic pemphigus 9.7
791 hutchinson-gilford progeria syndrome 9.7
792 pulmonary fibrosis, idiopathic 9.7
793 thyroid cancer, nonmedullary, 2 9.7
794 down syndrome 9.7
795 tuberous sclerosis 1 9.7
796 celiac disease 1 9.7
797 fanconi anemia, complementation group a 9.7
798 skin/hair/eye pigmentation, variation in, 2 9.7
799 retinitis pigmentosa 9.7
800 androgen insensitivity, partial 9.7
801 thrombocytopenia 1 9.7
802 oncocytoma 9.7
803 prostatic hyperplasia, benign 9.7
804 budd-chiari syndrome 9.7
805 astigmatism 9.7
806 becker nevus syndrome 9.7
807 diamond-blackfan anemia 2 9.7
808 pars planitis 9.7
809 mutagen sensitivity 9.7
810 cyanosis, transient neonatal 9.7
811 membranous nephropathy 9.7
812 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.7
813 joint laxity, short stature, and myopia 9.7
814 chronic ulcer of skin 9.7
815 cutaneous lupus erythematosus 9.7
816 hyperphosphatemia 9.7
817 gastrointestinal carcinoma 9.7
818 brain meningioma 9.7
819 pain agnosia 9.7
820 thyroid gland anaplastic carcinoma 9.7
821 myxofibrosarcoma 9.7
822 middle east respiratory syndrome 9.7
823 osteomyelitis 9.7
824 parotid disease 9.7
825 charcot-marie-tooth disease 9.7
826 protein-losing enteropathy 9.7
827 gastric ulcer 9.7
828 lepromatous leprosy 9.7
829 tooth disease 9.7
830 prostatic hypertrophy 9.7
831 erysipelas 9.7
832 cauda equina syndrome 9.7
833 penile benign neoplasm 9.7
834 myopia 9.7
835 vaginal cancer 9.7
836 esophagitis 9.7
837 hemosiderosis 9.7
838 graves' disease 9.7
839 tinea pedis 9.7
840 posterior uveitis 9.7
841 intermediate uveitis 9.7
842 plasmodium falciparum malaria 9.7
843 anus cancer 9.7
844 childhood type dermatomyositis 9.7
845 angioedema 9.7
846 alcohol use disorder 9.7
847 breast fibroadenoma 9.7
848 cystitis 9.7
849 conjunctival squamous cell carcinoma 9.7
850 hyperuricemia 9.7
851 hypogonadism 9.7
852 syringoma 9.7
853 granular cell tumor 9.7
854 hematologic cancer 9.7
855 chondroma 9.7
856 pigmented villonodular synovitis 9.7
857 hemangioma of liver 9.7
858 skin atrophy 9.7
859 laryngeal squamous cell carcinoma 9.7
860 prostatic adenoma 9.7
861 breast ductal carcinoma 9.7
862 grade iii astrocytoma 9.7
863 oligodendroglioma 9.7
864 melanotic neurilemmoma 9.7
865 embryonal carcinoma 9.7
866 plague 9.7
867 lactic acidosis 9.7
868 plexopathy 9.7
869 arthropathy 9.7
870 craniopharyngioma 9.7
871 hidradenoma 9.7
872 thyroid gland follicular carcinoma 9.7
873 thyroid gland medullary carcinoma 9.7
874 hypokalemia 9.7
875 mongolian spot 9.7
876 medulloepithelioma 9.7
877 cavernous hemangioma 9.7
878 human immunodeficiency virus infectious disease 9.7
879 t-cell lymphoblastic leukemia/lymphoma 9.7
880 axonal neuropathy 9.7
881 pseudosarcomatous fibromatosis 9.7
882 corneal ulcer 9.7
883 retinal degeneration 9.7
884 reticulosarcoma 9.7
885 lip cancer 9.7
886 decubitus ulcer 9.7
887 waardenburg's syndrome 9.7
888 priapism 9.7
889 fatty liver disease 9.7
890 pathologic nystagmus 9.7
891 muscular dystrophy 9.7
892 villonodular synovitis 9.7
893 allergic encephalomyelitis 9.7
894 autoimmune myocarditis 9.7
895 cerebellar degeneration 9.7
896 dendritic cell tumor 9.7
897 drug reaction with eosinophilia and systemic symptoms 9.7
898 leukemia, t-cell, chronic 9.7
899 mast cell activation syndrome 9.7
900 opsoclonus-myoclonus syndrome 9.7
901 rosai-dorfman disease 9.7
902 sinonasal undifferentiated carcinoma 9.7
903 triploidy 9.7
904 weber syndrome 9.7
905 depression 9.7
906 hypotonia 9.7
907 partial deletion of chromosome 3 9.7
908 onychomatricoma 9.7
909 primary cutaneous anaplastic large cell lymphoma 9.7
910 chronic enteropathy associated with slco2a1 gene 9.7
911 paraneoplastic pemphigus 9.7
912 rare genetic skin disease 9.7
913 discoid lupus erythematosus 9.7
914 premature aging 9.7
915 hyperpigmentation of the skin 9.7
916 cardiogenic shock 9.7
917 thrombotic microangiopathy 9.7
918 precursor t-cell acute lymphoblastic leukemia 9.7
919 alzheimer disease 9.6
920 anisocoria 9.6
921 epidermolytic hyperkeratosis 9.6
922 colchicine resistance 9.6
923 beckwith-wiedemann syndrome 9.6
924 gastric cancer, hereditary diffuse 9.6
925 lymphoma, mucosa-associated lymphoid type 9.6
926 hand skill, relative 9.6
927 heterochromia iridis 9.6
928 muir-torre syndrome 9.6
929 noonan syndrome 1 9.6
930 optic atrophy 1 9.6
931 pneumothorax, primary spontaneous 9.6
932 pulmonary hypertension, primary, 1 9.6
933 tobacco addiction 9.6
934 vasculitis, lymphocytic, nodular 9.6
935 vitreoretinopathy, neovascular inflammatory 9.6
936 albinism, oculocutaneous, type ia 9.6
937 alopecia universalis congenita 9.6
938 corneal dystrophy, band-shaped 9.6
939 cystinuria 9.6
940 dandy-walker syndrome 9.6
941 eosinophilic fasciitis 9.6
942 skin/hair/eye pigmentation, variation in, 5 9.6
943 gaucher disease, type i 9.6
944 hutterite cerebroosteonephrodysplasia syndrome 9.6
945 laurence-moon syndrome 9.6
946 myelofibrosis 9.6
947 netherton syndrome 9.6
948 nonarteritic anterior ischemic optic neuropathy 9.6
949 sjogren syndrome 9.6
950 intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked 9.6
951 coats disease 9.6
952 wiskott-aldrich syndrome 9.6
953 aging 9.6
954 gallbladder disease 1 9.6
955 deafness, autosomal dominant 5 9.6
956 retinitis pigmentosa 18 9.6
957 agammaglobulinemia 1, autosomal recessive 9.6
958 blue nevi, familial multiple 9.6
959 microvascular complications of diabetes 1 9.6
960 birdshot chorioretinopathy 9.6
961 alveolar soft part sarcoma 9.6
962 lymphangioleiomyomatosis 9.6
963 pulmonary disease, chronic obstructive 9.6
964 angioid streaks 9.6
965 epidermolysis bullosa simplex superficialis 9.6
966 niemann-pick disease, type c2 9.6
967 mycobacterium tuberculosis 1 9.6
968 buruli ulcer 9.6
969 skin/hair/eye pigmentation, variation in, 8 9.6
970 microtia, hearing impairment, and cleft palate 9.6
971 microvascular complications of diabetes 2 9.6
972 increased analgesia from kappa-opioid receptor agonist, female-specific 9.6
973 microcephaly, epilepsy, and diabetes syndrome 9.6
974 barrett esophagus 9.6
975 accelerated tumor formation 9.6
976 basal cell carcinoma 7 9.6
977 immunoskeletal dysplasia with neurodevelopmental abnormalities 9.6
978 visual impairment and progressive phthisis bulbi 9.6
979 hypertrophic scars 9.6
980 adrenal cortical carcinoma 9.6
981 superficial mycosis 9.6
982 brachydactyly 9.6
983 marginal zone b-cell lymphoma 9.6
984 limb ischemia 9.6
985 infective endocarditis 9.6
986 interleukin-7 receptor alpha deficiency 9.6
987 ductal carcinoma in situ 9.6
988 estrogen-receptor positive breast cancer 9.6
989 connective tissue benign neoplasm 9.6
990 diffuse alopecia areata 9.6
991 generalized epilepsy with febrile seizures plus 9.6
992 collagenous colitis 9.6
993 ileitis 9.6
994 ileocolitis 9.6
995 inguinal hernia 9.6
996 hepatic veno-occlusive disease 9.6
997 desmoid tumor 9.6
998 bone sarcoma 9.6
999 cerebral artery occlusion 9.6
1000 siderosis 9.6
1001 hypopyon 9.6
1002 common cold 9.6
1003 viral pneumonia 9.6
1004 meningoencephalitis 9.6
1005 pre-eclampsia 9.6
1006 microcephaly 9.6
1007 hemiplegia 9.6
1008 esophagus sarcoma 9.6
1009 common wart 9.6
1010 anogenital venereal wart 9.6
1011 t cell deficiency 9.6
1012 microcytic anemia 9.6
1013 rabies 9.6
1014 arteriovenous malformation 9.6
1015 pneumocystosis 9.6
1016 adult respiratory distress syndrome 9.6
1017 heart disease 9.6
1018 choroiditis 9.6
1019 penile cancer 9.6
1020 inflamed seborrheic keratosis 9.6
1021 leukocoria 9.6
1022 multicentric reticulohistiocytosis 9.6
1023 vaginal disease 9.6
1024 pulmonary alveolar proteinosis 9.6
1025 chagas disease 9.6
1026 pseudoretinitis pigmentosa 9.6
1027 bell's palsy 9.6
1028 hepatic coma 9.6
1029 quadriplegia 9.6
1030 typhoid fever 9.6
1031 eclampsia 9.6
1032 patent foramen ovale 9.6
1033 mature cataract 9.6
1034 amenorrhea 9.6
1035 peptic esophagitis 9.6
1036 adult-onset still's disease 9.6
1037 niemann-pick disease 9.6
1038 chromoblastomycosis 9.6
1039 peritoneal mesothelioma 9.6
1040 islet cell tumor 9.6
1041 status epilepticus 9.6
1042 gaucher's disease 9.6
1043 benign giant cell tumor 9.6
1044 connective tissue cancer 9.6
1045 hyperinsulinism 9.6
1046 hepatitis b 9.6
1047 nodular hidradenoma 9.6
1048 vulva squamous cell carcinoma 9.6
1049 transient cerebral ischemia 9.6
1050 hidradenitis suppurativa 9.6
1051 hidradenitis 9.6
1052 gastroenteritis 9.6
1053 arteriosclerosis 9.6
1054 acromegaly 9.6
1055 splenic infarction 9.6
1056 larynx cancer 9.6
1057 idiopathic interstitial pneumonia 9.6
1058 anuria 9.6
1059 iga glomerulonephritis 9.6
1060 allergic contact dermatitis 9.6
1061 small cell sarcoma 9.6
1062 lipid metabolism disorder 9.6
1063 inverted papilloma 9.6
1064 cerebellopontine angle tumor 9.6
1065 demyelinating disease 9.6
1066 orbit rhabdomyosarcoma 9.6
1067 spindle cell thymoma 9.6
1068 fibrosarcoma of bone 9.6
1069 inappropriate adh syndrome 9.6
1070 neurofibrosarcoma 9.6
1071 appendix adenocarcinoma 9.6
1072 angiolipoma 9.6
1073 aortic aneurysm 9.6
1074 verrucous carcinoma 9.6
1075 pleural empyema 9.6
1076 cranial nerve palsy 9.6
1077 lung squamous cell carcinoma 9.6
1078 acute myocarditis 9.6
1079 lymphocytic gastritis 9.6
1080 tricuspid valve stenosis 9.6
1081 nail disease 9.6
1082 pseudohypoparathyroidism 9.6
1083 hypertrichosis 9.6
1084 fibroepithelial basal cell carcinoma 9.6
1085 polyradiculoneuropathy 9.6
1086 spongiotic dermatitis 9.6
1087 hepatitis e 9.6
1088 rhinitis 9.6
1089 mucoepidermoid carcinoma 9.6
1090 large cell carcinoma 9.6
1091 epidermolysis bullosa simplex 9.6
1092 intraocular retinoblastoma 9.6
1093 perineurioma 9.6
1094 somatoform disorder 9.6
1095 movement disease 9.6
1096 pleomorphic xanthoastrocytoma 9.6
1097 bronchiolo-alveolar adenocarcinoma 9.6
1098 optic nerve glioma 9.6
1099 thyroid gland disease 9.6
1100 rhabdoid meningioma 9.6
1101 basosquamous carcinoma 9.6
1102 ganglioglioma 9.6
1103 ovarian cyst 9.6
1104 cutaneous leiomyosarcoma 9.6
1105 pulmonary coin lesion 9.6
1106 dystonia 9.6
1107 monophasic synovial sarcoma 9.6
1108 adenoid squamous cell carcinoma 9.6
1109 chiasmal syndrome 9.6
1110 lymphoepithelioma-like carcinoma 9.6
1111 pleomorphic liposarcoma 9.6
1112 inflammatory breast carcinoma 9.6
1113 diffuse meningeal melanocytosis 9.6
1114 progressive multifocal leukoencephalopathy 9.6
1115 cerebrovascular disease 9.6
1116 diverticulitis 9.6
1117 periodontitis 9.6
1118 scabies 9.6
1119 epithelioid malignant peripheral nerve sheath tumor 9.6
1120 paralytic ileus 9.6
1121 impetigo 9.6
1122 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.6
1123 oral cavity cancer 9.6
1124 subacute delirium 9.6
1125 bacterial pneumonia 9.6
1126 rubella 9.6
1127 intermediate coronary syndrome 9.6
1128 pityriasis rosea 9.6
1129 pityriasis versicolor 9.6
1130 viral infectious disease 9.6
1131 allergic asthma 9.6
1132 noma 9.6
1133 yellow fever 9.6
1134 tenosynovitis 9.6
1135 vitreous detachment 9.6
1136 refractive error 9.6
1137 meibomian cyst 9.6
1138 lrrk2 parkinson disease 9.6
1139 actinic cheilitis 9.6
1140 angiosarcoma of the scalp 9.6
1141 aortopulmonary window 9.6
1142 autoimmune encephalitis 9.6
1143 bednar tumor 9.6
1144 broken heart syndrome 9.6
1145 carcinoid syndrome 9.6
1146 chromosome 6p duplication 9.6
1147 chronic graft versus host disease 9.6
1148 cutis verticis gyrata 9.6
1149 epidermoid brain cyst 9.6
1150 frontal fibrosing alopecia 9.6
1151 laugier-hunziker syndrome 9.6
1152 leukoplakia 9.6
1153 limbic encephalitis 9.6
1154 lymphomatoid papulosis 9.6
1155 mycetoma 9.6
1156 paraneoplastic cerebellar degeneration 9.6
1157 pituitary stalk interruption syndrome 9.6
1158 pityriasis lichenoides 9.6
1159 plasmablastic lymphoma 9.6
1160 pontine hemorrhage 9.6
1161 pseudo-turner syndrome 9.6
1162 remitting seronegative symmetrical synovitis with pitting edema 9.6
1163 ring chromosome 7 9.6
1164 spastic paraparesis 9.6
1165 tuberculous meningitis 9.6
1166 urethral cancer 9.6
1167 cavernous malformation 9.6
1168 fainting 9.6
1169 pituitary tumors 9.6
1170 subacute cutaneous lupus erythematosus 9.6
1171 malignant peritoneal mesothelioma 9.6
1172 mixed germ cell tumor 9.6
1173 systemic autoimmune disease 9.6
1174 rare hereditary hemochromatosis 9.6
1175 acute sensory ataxic neuropathy 9.6
1176 rare nevus 9.6
1177 malignant tumor of penis 9.6
1178 acute adrenal insufficiency 9.6
1179 refractory anemia 9.6
1180 vitreoretinopathy 9.6
1181 thyroid tumor 9.6
1182 aortic aneurysm, familial abdominal, 1 9.5
1183 pfeiffer syndrome 9.5
1184 tietz albinism-deafness syndrome 9.5
1185 alcohol dependence 9.5
1186 spondyloarthropathy 1 9.5
1187 apnea, obstructive sleep 9.5
1188 arteries, anomalies of 9.5
1189 gastroesophageal reflux 9.5
1190 b-cell growth factor 9.5
1191 blue rubber bleb nevus 9.5
1192 branchiooculofacial syndrome 9.5
1193 breast cancer-related regulator of tp53 9.5
1194 campomelic dysplasia 9.5
1195 cardiac arrhythmia 9.5
1196 charcot-marie-tooth disease, demyelinating, type 1b 9.5
1197 chlorpropamide-alcohol flushing 9.5
1198 seizures, benign familial neonatal, 1 9.5
1199 creutzfeldt-jakob disease 9.5
1200 darier-white disease 9.5
1201 deafness, unilateral 9.5
1202 dilution, pigmentary 9.5
1203 preauricular fistulae, congenital 9.5
1204 clouston syndrome 9.5
1205 ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 1 9.5
1206 endometriosis 1 9.5
1207 fucosidase regulator 9.5
1208 hirschsprung disease 1 9.5
1209 gilbert syndrome 9.5
1210 hyperhidrosis, gustatory 9.5
1211 endosteal hyperostosis, autosomal dominant 9.5
1212 hypertelorism 9.5
1213 ichthyosis vulgaris 9.5
1214 keloid formation 9.5
1215 klippel-trenaunay-weber syndrome 9.5
1216 lacrimal duct defect 9.5
1217 hereditary leiomyomatosis and renal cell cancer 9.5
1218 lentiginosis, inherited patterned 9.5
1219 leopard syndrome 1 9.5
1220 migraine with or without aura 1 9.5
1221 motion sickness 9.5
1222 facioscapulohumeral muscular dystrophy 1 9.5
1223 myotonic dystrophy 1 9.5
1224 multiple endocrine neoplasia, type iib 9.5
1225 neutrophil migration 9.5
1226 nevus anemicus 9.5
1227 night blindness, congenital stationary, autosomal dominant 2 9.5
1228 ocular cicatricial pemphigoid 9.5
1229 obsessive-compulsive disorder 9.5
1230 optic nerve hypoplasia, bilateral 9.5
1231 osteoporosis 9.5
1232 phosphatase, acid, of tissues 9.5
1233 piebald trait 9.5
1234 kindler syndrome 9.5
1235 porphyria cutanea tarda 9.5
1236 pelvic organ prolapse 9.5
1237 exfoliation syndrome 9.5
1238 pulmonary nodular lymphoid hyperplasia, familial 9.5
1239 spinal arachnoiditis 9.5
1240 split-hand/foot malformation 1 9.5
1241 sturge-weber syndrome 9.5
1242 thrombocytopenia 2 9.5
1243 digeorge syndrome 9.5
1244 trichomegaly 9.5
1245 varicose veins 9.5
1246 volvulus of midgut 9.5
1247 waardenburg syndrome, type 2a 9.5
1248 wilms tumor 3 9.5
1249 acrodermatitis enteropathica, zinc-deficiency type 9.5
1250 adrenocortical carcinoma, hereditary 9.5
1251 hermansky-pudlak syndrome 1 9.5
1252 alopecia-epilepsy-oligophrenia syndrome of moynahan 9.5
1253 antley-bixler syndrome without genital anomalies or disordered steroidogenesis 9.5
1254 bardet-biedl syndrome 1 9.5
1255 craniometaphyseal dysplasia, autosomal recessive 9.5
1256 cryptorchidism, unilateral or bilateral 9.5
1257 cystic fibrosis 9.5
1258 leukoencephalopathy, hereditary diffuse, with spheroids 9.5
1259 ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive 9.5
1260 skin/hair/eye pigmentation, variation in, 1 9.5
1261 factor x deficiency 9.5
1262 hemochromatosis, type 1 9.5
1263 laryngoonychocutaneous syndrome 9.5
1264 nijmegen breakage syndrome 9.5
1265 muscular dystrophy, limb-girdle, autosomal recessive 1 9.5
1266 myxedema 9.5
1267 neuroblastoma 1 9.5
1268 phenylketonuria 9.5
1269 polycythemia vera 9.5
1270 pulmonary alveolar microlithiasis 9.5
1271 rhabdomyosarcoma 2 9.5
1272 roberts syndrome 9.5
1273 rothmund-thomson syndrome, type 2 9.5
1274 sc phocomelia syndrome 9.5
1275 short stature-obesity syndrome 9.5
1276 smith-lemli-opitz syndrome 9.5
1277 thrombocytopenia 3 9.5
1278 xeroderma pigmentosum, complementation group g 9.5
1279 opitz gbbb syndrome, type i 9.5
1280 androgen insensitivity syndrome 9.5
1281 fragile x syndrome 9.5
1282 cataract 40 9.5
1283 hemophilia a 9.5
1284 incontinentia pigmenti 9.5
1285 muscular dystrophy, duchenne type 9.5
1286 ouabain resistance 9.5
1287 helicobacter pylori infection 9.5
1288 aminopterin syndrome sine aminopterin 9.5
1289 pituitary adenoma, prolactin-secreting 9.5
1290 palmoplantar keratoderma, nonepidermolytic 9.5
1291 cd4/cd8 t-cell ratio 9.5
1292 dermatitis herpetiformis, familial 9.5
1293 stroke, ischemic 9.5
1294 inflammatory bowel disease 2 9.5
1295 paragangliomas 2 9.5
1296 malignant atrophic papulosis 9.5
1297 schizophrenia 2 9.5
1298 sickle cell anemia 9.5
1299 psoriasis 4 9.5
1300 systemic lupus erythematosus 2 9.5
1301 psoriasis 6 9.5
1302 paragangliomas 3 9.5
1303 albinism, oculocutaneous, type iv 9.5
1304 creatinine clearance quantitative trait locus 9.5
1305 allergic rhinitis 9.5
1306 retinitis pigmentosa 30 9.5
1307 kala-azar 1 9.5
1308 lung cancer susceptibility 1 9.5
1309 fanconi anemia, complementation group i 9.5
1310 west nile virus 9.5
1311 hamamy syndrome 9.5
1312 colorectal cancer 2 9.5
1313 cataract 47 9.5
1314 histiocytoma, angiomatoid fibrous 9.5
1315 colorectal cancer 5 9.5
1316 chondrosarcoma, extraskeletal myxoid 9.5
1317 skin/hair/eye pigmentation, variation in, 11 9.5
1318 adiponectin, serum level of, quantitative trait locus 1 9.5
1319 multiple sclerosis 2 9.5
1320 premature ovarian failure 7 9.5
1321 palmoplantar keratoderma, nonepidermolytic, focal 1 9.5
1322 neuroblastoma 5 9.5
1323 basal cell carcinoma 2 9.5
1324 basal cell carcinoma 3 9.5
1325 basal cell carcinoma 4 9.5
1326 basal cell carcinoma 6 9.5
1327 myxoid liposarcoma 9.5
1328 ectodermal dysplasia-syndactyly syndrome 2 9.5
1329 cataract 36 9.5
1330 hermansky-pudlak syndrome 6 9.5
1331 microcephaly-capillary malformation syndrome 9.5
1332 dengue virus 9.5
1333 bacteremia 2 9.5
1334 hemorrhage, intracerebral 9.5
1335 palmoplantar keratoderma, mutilating, with periorificial keratotic plaques 9.5
1336 human herpesvirus 8 9.5
1337 peroxisome biogenesis disorder 10a 9.5
1338 riboflavin deficiency 9.5
1339 palmoplantar carcinoma, multiple self-healing 9.5
1340 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 9.5
1341 alacrima, achalasia, and mental retardation syndrome 9.5
1342 hyperprolactinemia 9.5
1343 vulto-van silfhout-de vries syndrome 9.5
1344 tatton-brown-rahman syndrome 9.5
1345 silver-russell syndrome 3 9.5
1346 cataract 45 9.5
1347 heart and brain malformation syndrome 9.5
1348 hydrops, lactic acidosis, and sideroblastic anemia 9.5
1349 hyperlipoproteinemia, type iii 9.5
1350 neuropathy, congenital hypomyelinating, 2 9.5
1351 noonan syndrome 11 9.5
1352 lipoprotein quantitative trait locus 9.5
1353 pulmonary hypertension 9.5
1354 bacterial sepsis 9.5
1355 polyomavirus-associated nephropathy 9.5
1356 drug-induced lupus erythematosus 9.5
1357 erysipeloid 9.5
1358 dengue shock syndrome 9.5
1359 inflammatory diarrhea 9.5
1360 aspiration pneumonia 9.5
1361 swine influenza 9.5
1362 congenital hypothyroidism 9.5
1363 usher syndrome 9.5
1364 brugada syndrome 9.5
1365 ocular albinism 9.5
1366 persistent mullerian duct syndrome 9.5
1367 third-degree atrioventricular block 9.5
1368 hemorrhagic cystitis 9.5
1369 villous adenoma 9.5
1370 ameloblastoma 9.5
1371 colon adenoma 9.5
1372 sexual disorder 9.5
1373 marantic endocarditis 9.5
1374 brain glioma 9.5
1375 apraxia 9.5
1376 visual agnosia 9.5
1377 ischemic colitis 9.5
1378 microscopic colitis 9.5
1379 crest syndrome 9.5
1380 atrial fibrillation 9.5
1381 dowling-degos disease 9.5
1382 gallbladder disease 9.5
1383 lung abscess 9.5
1384 umbilical hernia 9.5
1385 mastoiditis 9.5
1386 cervical polyp 9.5
1387 ectopic pregnancy 9.5
1388 drug allergy 9.5
1389 spinal disease 9.5
1390 recessive dystrophic epidermolysis bullosa 9.5
1391 griscelli syndrome 9.5
1392 early-onset parkinson's disease 9.5
1393 congenital fiber-type disproportion 9.5
1394 myoglobinuria 9.5
1395 childhood acute lymphocytic leukemia 9.5
1396 lymphoblastic lymphoma 9.5
1397 non-alcoholic fatty liver disease 9.5
1398 nodal marginal zone lymphoma 9.5
1399 acquired generalized lipodystrophy 9.5
1400 malignant pheochromocytoma 9.5
1401 lung non-squamous non-small cell carcinoma 9.5
1402 hyperprolinemia 9.5
1403 coronavirus infectious disease 9.5
1404 cataract 30 9.5
1405 acquired von willebrand syndrome 9.5
1406 endometritis 9.5
1407 duodenum cancer 9.5
1408 corneal disease 9.5
1409 keratoconus 9.5
1410 venous insufficiency 9.5
1411 thymus lymphoma 9.5
1412 brown's tendon sheath syndrome 9.5
1413 pleurisy 9.5
1414 parotitis 9.5
1415 anthracosis 9.5
1416 chronic meningitis 9.5
1417 breast cyst 9.5
1418 chronic leukemia 9.5
1419 suppression amblyopia 9.5
1420 amblyopia 9.5
1421 perforated corneal ulcer 9.5
1422 nasopharyngitis 9.5
1423 gastric lymphoma 9.5
1424 microinvasive gastric cancer 9.5
1425 allergic urticaria 9.5
1426 methemoglobinemia 9.5
1427 filariasis 9.5
1428 nasal cavity cancer 9.5
1429 dirofilariasis 9.5
1430 meningocele 9.5
1431 hypospadias 9.5
1432 pinguecula 9.5
1433 pasteurellosis 9.5
1434 myiasis 9.5
1435 pulpitis 9.5
1436 miliaria rubra 9.5
1437 hypoparathyroidism 9.5
1438 pituitary apoplexy 9.5
1439 lens subluxation 9.5
1440 corneal neovascularization 9.5
1441 alternating exotropia 9.5
1442 exotropia 9.5
1443 acquired night blindness 9.5
1444 mitral valve insufficiency 9.5
1445 listeriosis 9.5
1446 scleral staphyloma 9.5
1447 infant gynecomastia 9.5
1448 polycystic ovary syndrome 9.5
1449 palindromic rheumatism 9.5
1450 diabetic angiopathy 9.5
1451 absolute glaucoma 9.5
1452 hepatorenal syndrome 9.5
1453 degenerative myopia 9.5
1454 visual epilepsy 9.5
1455 hypertrophic cardiomyopathy 9.5
1456 inflammatory spondylopathy 9.5
1457 pica disease 9.5
1458 neurogenic bladder 9.5
1459 arachnoiditis 9.5
1460 otosclerosis 9.5
1461 dengue disease 9.5
1462 dengue hemorrhagic fever 9.5
1463 cartilage disease 9.5
1464 secondary hyperparathyroidism of renal origin 9.5
1465 secondary hyperparathyroidism 9.5
1466 hemolytic-uremic syndrome 9.5
1467 acute kidney tubular necrosis 9.5
1468 phacolytic glaucoma 9.5
1469 hypertrophic pyloric stenosis 9.5
1470 pyloric stenosis 9.5
1471 blastomycosis 9.5
1472 gynecomastia 9.5
1473 tolosa-hunt syndrome 9.5
1474 ocular motility disease 9.5
1475 hypochondriasis 9.5
1476 miller fisher syndrome 9.5
1477 dilated cardiomyopathy 9.5
1478 lagophthalmos 9.5
1479 plasmodium vivax malaria 9.5
1480 traumatic glaucoma 9.5
1481 dementia 9.5
1482 tinea unguium 9.5
1483 branch retinal artery occlusion 9.5
1484 focal segmental glomerulosclerosis 9.5
1485 acute cystitis 9.5
1486 porphyria 9.5
1487 color blindness 9.5
1488 neurosarcoidosis 9.5
1489 hepatic encephalopathy 9.5
1490 corneal argyrosis 9.5
1491 osteopetrosis 9.5
1492 optic disk drusen 9.5
1493 photokeratitis 9.5
1494 pharyngoconjunctival fever 9.5
1495 miliaria 9.5
1496 facial neuralgia 9.5
1497 sick sinus syndrome 9.5
1498 chronic orbital inflammation 9.5
1499 poems syndrome 9.5
1500 phaeohyphomycosis 9.5
1501 choroid disease 9.5
1502 central neurocytoma 9.5
1503 frozen shoulder 9.5
1504 ochronosis 9.5
1505 azoospermia 9.5
1506 acute thyroiditis 9.5
1507 gonadal dysgenesis 9.5
1508 sporotrichosis 9.5
1509 dumping syndrome 9.5
1510 echinococcosis 9.5
1511 disease of mental health 9.5
1512 candidiasis 9.5
1513 personality disorder 9.5
1514 pleural disease 9.5
1515 fungal infectious disease 9.5
1516 mechanical ectropion 9.5
1517 communicating hydrocephalus 9.5
1518 limited scleroderma 9.5
1519 endogenous depression 9.5
1520 mental depression 9.5
1521 breast adenoma 9.5
1522 benign breast phyllodes tumor 9.5
1523 histoplasmosis 9.5
1524 mitral valve stenosis 9.5
1525 urethral stricture 9.5
1526 gestational choriocarcinoma 9.5
1527 drug-induced hepatitis 9.5
1528 post-traumatic stress disorder 9.5
1529 vulvar disease 9.5
1530 bartholin's gland benign neoplasm 9.5
1531 nasal cavity disease 9.5
1532 carbuncle 9.5
1533 factor xiii deficiency 9.5
1534 essential thrombocythemia 9.5
1535 pharyngitis 9.5
1536 leptospirosis 9.5
1537 nocardiosis 9.5
1538 myelophthisic anemia 9.5
1539 glomus tumor 9.5
1540 glomangioma 9.5
1541 chronic conjunctivitis 9.5
1542 agammaglobulinemia 9.5
1543 adenomyoma 9.5
1544 cystadenoma 9.5
1545 struma ovarii 9.5
1546 sebaceous adenoma 9.5
1547 myoepithelioma 9.5
1548 myoma 9.5
1549 leydig cell tumor 9.5
1550 phimosis 9.5
1551 acrodermatitis 9.5
1552 capillary hemangioma 9.5
1553 parasitic protozoa infectious disease 9.5
1554 acalculous cholecystitis 9.5
1555 glucosephosphate dehydrogenase deficiency 9.5
1556 endometrial adenocarcinoma 9.5
1557 cryoglobulinemia 9.5
1558 membranoproliferative glomerulonephritis 9.5
1559 inner ear disease 9.5
1560 pleomorphic adenoma carcinoma 9.5
1561 breast malignant phyllodes tumor 9.5
1562 churg-strauss syndrome 9.5
1563 gliosarcoma 9.5
1564 cystic lymphangioma 9.5
1565 papillary adenocarcinoma 9.5
1566 gastrointestinal system cancer 9.5
1567 gallbladder cancer 9.5
1568 proctitis 9.5
1569 cutis laxa 9.5
1570 verrucous papilloma 9.5
1571 skin papilloma 9.5
1572 cellular schwannoma 9.5
1573 neurilemmoma of the fifth cranial nerve 9.5
1574 central nervous system lymphoma 9.5
1575 lipid pneumonia 9.5
1576 embryonal rhabdomyosarcoma 9.5
1577 chronic granulomatous disease 9.5
1578 neurodermatitis 9.5
1579 hepatic angiomyolipoma 9.5
1580 uveal disease 9.5
1581 turner syndrome 9.5
1582 mixed connective tissue disease 9.5
1583 signet ring cell adenocarcinoma 9.5
1584 middle cerebral artery infarction 9.5
1585 choroid plexus cancer 9.5
1586 lateral sinus thrombosis 9.5
1587 pancreatic ductal carcinoma 9.5
1588 toxic encephalopathy 9.5
1589 central nervous system cancer 9.5
1590 intermittent claudication 9.5
1591 lung benign neoplasm 9.5
1592 extramedullary plasmacytoma 9.5
1593 hermansky-pudlak syndrome 9.5
1594 insulinoma 9.5
1595 hidrocystoma 9.5
1596 adrenal cortical adenocarcinoma 9.5
1597 bartholin's gland carcinoma 9.5
1598 bladder urothelial carcinoma 9.5
1599 ectomesenchymoma 9.5
1600 tricuspid valve insufficiency 9.5
1601 liver disease 9.5
1602 agnosia 9.5
1603 orbital cancer 9.5
1604 ganglioneuroblastoma 9.5
1605 endometrial stromal sarcoma 9.5
1606 coronary stenosis 9.5
1607 conjunctival disease 9.5
1608 metatypical basal cell carcinoma 9.5
1609 morpheaform basal cell carcinoma 9.5
1610 clear cell basal cell carcinoma 9.5
1611 infiltrative basal cell carcinoma 9.5
1612 bone giant cell tumor 9.5
1613 polyradiculopathy 9.5
1614 large cell acanthoma 9.5
1615 erdheim-chester disease 9.5
1616 non-langerhans-cell histiocytosis 9.5
1617 tinea capitis 9.5
1618 myofibroma 9.5
1619 reticulohistiocytic granuloma 9.5
1620 phototoxic dermatitis 9.5
1621 clear cell adenocarcinoma 9.5
1622 avian influenza 9.5
1623 breast angiosarcoma 9.5
1624 hypotrichosis 9.5
1625 mesenchymal chondrosarcoma 9.5
1626 extraosseous chondrosarcoma 9.5
1627 lung large cell carcinoma 9.5
1628 intestinal benign neoplasm 9.5
1629 breast metaplastic carcinoma 9.5
1630 skin hemangioma 9.5
1631 brain edema 9.5
1632 calciphylaxis 9.5
1633 pulmonary blastoma 9.5
1634 rapidly progressive glomerulonephritis 9.5
1635 proliferative glomerulonephritis 9.5
1636 adenosquamous carcinoma 9.5
1637 myoepithelial carcinoma 9.5
1638 lymph node tuberculosis 9.5
1639 adenocarcinoma in situ 9.5
1640 sclerosing hemangioma 9.5
1641 central nervous system melanocytic neoplasm 9.5
1642 epidermolysis bullosa dystrophica 9.5
1643 gerstmann syndrome 9.5
1644 prosopagnosia 9.5
1645 elephantiasis 9.5
1646 essential tremor 9.5
1647 fibrolamellar carcinoma 9.5
1648 malignant granular cell myoblastoma 9.5
1649 dermoid cyst of ovary 9.5
1650 leiomyomatosis 9.5
1651 plexiform neurofibroma 9.5
1652 aortitis 9.5
1653 hemangioblastoma 9.5
1654 central nervous system vasculitis 9.5
1655 intestinal disease 9.5
1656 pituitary gland disease 9.5
1657 sleep disorder 9.5
1658 colonic disease 9.5
1659 internuclear ophthalmoplegia 9.5
1660 brain angioma 9.5
1661 clear cell hidradenoma 9.5
1662 syringocystadenoma papilliferum 9.5
1663 spindle cell synovial sarcoma 9.5
1664 keratinizing squamous cell carcinoma 9.5
1665 anal squamous cell carcinoma 9.5
1666 malignant teratoma 9.5
1667 malignant acrospiroma 9.5
1668 lung giant cell carcinoma 9.5
1669 t-cell acute lymphoblastic leukemia 9.5
1670 retinal disease 9.5
1671 hereditary breast ovarian cancer syndrome 9.5
1672 well-differentiated liposarcoma 9.5
1673 cellular myxoid liposarcoma 9.5
1674 intravenous leiomyomatosis 9.5
1675 nerve compression syndrome 9.5
1676 malignant mesenchymoma 9.5
1677 hemoglobinuria 9.5
1678 myxoid chondrosarcoma 9.5
1679 eosinophilic pneumonia 9.5
1680 angiokeratoma of mibelli 9.5
1681 angiokeratoma circumscriptum 9.5
1682 microglandular adenosis 9.5
1683 juvenile type testicular granulosa cell tumor 9.5
1684 esophageal disease 9.5
1685 malignant leptomeningeal tumor 9.5
1686 acute stress disorder 9.5
1687 jugular foramen meningioma 9.5
1688 ovarian carcinosarcoma 9.5
1689 ovarian small cell carcinoma 9.5
1690 cornea cancer 9.5
1691 renal oncocytoma 9.5
1692 eyelid carcinoma 9.5
1693 adrenal adenoma 9.5
1694 spondylitis 9.5
1695 fibrillary astrocytoma 9.5
1696 bilateral breast cancer 9.5
1697 juvenile rheumatoid arthritis 9.5
1698 juvenile pilocytic astrocytoma 9.5
1699 skin tag 9.5
1700 meningothelial meningioma 9.5
1701 nodular episcleritis 9.5
1702 male urethral cancer 9.5
1703 cutaneous anthrax 9.5
1704 enterobiasis 9.5
1705 malignant pleural mesothelioma 9.5
1706 peptic ulcer disease 9.5
1707 squamous papillomatosis 9.5
1708 stomach disease 9.5
1709 gastrointestinal system disease 9.5
1710 retinal telangiectasia 9.5
1711 placenta disease 9.5
1712 chronic kidney disease 9.5
1713 mite infestation 9.5
1714 sporadic breast cancer 9.5
1715 carotid artery occlusion 9.5
1716 osteoarthritis 9.5
1717 kidney angiomyolipoma 9.5
1718 polycythemia 9.5
1719 actinomycosis 9.5
1720 retinal artery occlusion 9.5
1721 mucormycosis 9.5
1722 bullous skin disease 9.5
1723 dermatitis herpetiformis 9.5
1724 monocytic leukemia 9.5
1725 malignant hyperthermia 9.5
1726 oropharynx cancer 9.5
1727 herpetic whitlow 9.5
1728 gastroduodenitis 9.5
1729 myeloid sarcoma 9.5
1730 neuromyelitis optica 9.5
1731 learning disability 9.5
1732 autosomal dominant polycystic kidney disease 9.5
1733 leishmaniasis 9.5
1734 macroglobulinemia 9.5
1735 parapsoriasis 9.5
1736 rem sleep behavior disorder 9.5
1737 amyloidosis 9.5
1738 eczema herpeticum 9.5
1739 achalasia 9.5
1740 speech disorder 9.5
1741 nasal cavity benign neoplasm 9.5
1742 lymphangitis 9.5
1743 orbital plasma cell granuloma 9.5
1744 acute myocardial infarction 9.5
1745 blepharitis 9.5
1746 hypertensive encephalopathy 9.5
1747 exposure keratitis 9.5
1748 necrotizing fasciitis 9.5
1749 systolic heart failure 9.5
1750 senile cataract 9.5
1751 vitreous disease 9.5
1752 diabetic neuropathy 9.5
1753 emphysematous cholecystitis 9.5
1754 irritable bowel syndrome 9.5
1755 toxocariasis 9.5
1756 hypertropia 9.5
1757 peripheral vertigo 9.5
1758 toxic maculopathy 9.5
1759 hypoplastic left heart syndrome 9.5
1760 hemophilia 9.5
1761 hyperphenylalaninemia 9.5
1762 limb-girdle muscular dystrophy 9.5
1763 ankrd26-related thrombocytopenia 9.5
1764 apc-associated polyposis conditions 9.5
1765 esco2 spectrum disorder 9.5
1766 sickle cell disease 9.5
1767 actinic lichen planus 9.5
1768 acute graft versus host disease 9.5
1769 acute monoblastic leukemia 9.5
1770 acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) 9.5
1771 allergic angiitis 9.5
1772 antisynthetase syndrome 9.5
1773 autoimmune autonomic ganglionopathy 9.5
1774 autoimmune inner ear disease 9.5
1775 basal cell carcinoma, multiple 9.5
1776 blastic plasmacytoid dendritic cell 9.5
1777 bronchogenic cyst 9.5
1778 bronchopulmonary dysplasia 9.5
1779 buschke lowenstein tumor 9.5
1780 cardiac rupture 9.5
1781 cerebrospinal fluid leak 9.5
1782 chromosome 1p deletion 9.5
1783 chromosome 6q deletion 9.5
1784 chromosome 8q duplication 9.5
1785 cold agglutinin disease 9.5
1786 coloboma of iris 9.5
1787 diffuse idiopathic pulmonary neuroendocrine cell hyperplasia 9.5
1788 eales disease 9.5
1789 enteropathica 9.5
1790 erythroplakia 9.5
1791 exfoliative dermatitis 9.5
1792 gastro-enteropancreatic neuroendocrine tumor 9.5
1793 hemangioendothelioma 9.5
1794 hemorrhagic shock and encephalopathy syndrome 9.5
1795 hypomelanotic disorder 9.5
1796 ichthyosis, acquired 9.5
1797 indolent b cell lymphoma 9.5
1798 inflammatory linear verrucous epidermal nevus 9.5
1799 intravascular papillary endothelial hyperplasia 9.5
1800 kikuchi disease 9.5
1801 ledderhose disease 9.5
1802 lichen planus pemphigoides 9.5
1803 lichen planus pigmentosus 9.5
1804 linear porokeratosis 9.5
1805 lymphangiectasis 9.5
1806 lymphangiomatosis 9.5
1807 macrophage activation syndrome 9.5
1808 muscular dystrophy white matter spongiosis 9.5
1809 myelodysplastic syndrome with excess blasts 9.5
1810 necrotizing autoimmune myopathy 9.5
1811 ocular toxoplasmosis 9.5
1812 onychocytic matricoma 9.5
1813 paraneoplastic neurologic disorders 9.5
1814 pemphigus foliaceus 9.5
1815 phocomelia 9.5
1816 piriformis syndrome 9.5
1817 pityriasis lichenoides chronica 9.5
1818 primary central nervous system lymphoma 9.5
1819 proliferating trichilemmal cyst 9.5
1820 prosthetic joint infection 9.5
1821 pustular psoriasis 9.5
1822 renal cell carcinoma 4 9.5
1823 ring chromosome 11 9.5
1824 ring chromosome 2 9.5
1825 ring chromosome 3 9.5
1826 secondary adrenal insufficiency 9.5
1827 sinus cancer 9.5
1828 superficial siderosis of the central nervous system 9.5
1829 telangiectasia macularis eruptive perstans 9.5
1830 transverse myelitis 9.5
1831 true thymic hyperplasia 9.5
1832 uterine sarcoma 9.5
1833 mda5 deficiency 9.5
1834 cerebral aneurysms 9.5
1835 foot drop 9.5
1836 hypertonia 9.5
1837 myotonia 9.5
1838 occipital neuralgia 9.5
1839 seizure disorder 9.5
1840 paraneoplastic limbic encephalitis 9.5
1841 rare viral disease 9.5
1842 rare cardiac tumor 9.5
1843 b-cell non-hodgkin lymphoma 9.5
1844 perioral myoclonia with absences 9.5
1845 vulvar intraepithelial neoplasia 9.5
1846 isolated split hand-split foot malformation 9.5
1847 superficial siderosis 9.5
1848 autosomal dominant epidermolytic ichthyosis 9.5
1849 anomaly of chromosome 7 9.5
1850 partial deletion of the long arm of chromosome 3 9.5
1851 anomaly of chromosome 1 9.5
1852 anomaly of chromosome 4 9.5
1853 pouchitis 9.5
1854 primary cutaneous lymphoma 9.5
1855 cranial neuralgia 9.5
1856 peripheral hypothyroidism 9.5
1857 scalp syndrome 9.5
1858 fixed drug eruption 9.5
1859 pre-descemet corneal dystrophy 9.5
1860 acute generalized exanthematous pustulosis 9.5
1861 ovarian fibroma 9.5
1862 verrucous hemangioma 9.5
1863 euthyroid graves orbitopathy 9.5
1864 persistent idiopathic facial pain 9.5
1865 primary lymphedema 9.5
1866 diffuse alveolar hemorrhage 9.5
1867 radiation myelitis 9.5
1868 histiocytic sarcoma 9.5
1869 classic phenylketonuria 9.5
1870 rare gynecological tumor 9.5
1871 solar urticaria 9.5
1872 coronary ostial stenosis or atresia 9.5
1873 acute motor and sensory axonal neuropathy 9.5
1874 essential iris atrophy 9.5
1875 rare movement disorder 9.5
1876 rare eye tumor 9.5
1877 polyendocrinopathy 9.5

Graphical network of the top 20 diseases related to Melanoma, Cutaneous Malignant 10:



Diseases related to Melanoma, Cutaneous Malignant 10

Symptoms & Phenotypes for Melanoma, Cutaneous Malignant 10

Human phenotypes related to Melanoma, Cutaneous Malignant 10:

31 (showing 1, show less)
# Description HPO Frequency HPO Source Accession
1 melanoma 31 HP:0002861

Symptoms via clinical synopsis from OMIM:

56
Neoplasia:
cutaneous malignant melanoma
possibly increased risk for other cancers

Clinical features from OMIM:

615848

Drugs & Therapeutics for Melanoma, Cutaneous Malignant 10

Drugs for Melanoma, Cutaneous Malignant 10 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 636, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vindesine Approved, Investigational Phase 4 59917-39-4, 53643-48-4 40839
2
Pravastatin Approved Phase 4 81093-37-0 54687
3
Salicylic acid Approved, Investigational, Vet_approved Phase 4 69-72-7 338
4
Ciclopirox Approved, Investigational Phase 4 29342-05-0 2749
5
Infliximab Approved Phase 4 170277-31-3
6
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
7
Citalopram Approved Phase 4 59729-33-8 2771
8
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741
9
Selegiline Approved, Investigational, Vet_approved Phase 4 14611-51-9 5195 26757
10
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
11
Aminolevulinic acid Approved Phase 4 106-60-5 137
12
Fluorouracil Approved Phase 4 51-21-8 3385
13
Menthol Approved Phase 4 2216-51-5 16666
14
Etanercept Approved, Investigational Phase 4 185243-69-0
15
Lactitol Approved, Investigational Phase 4 585-88-6, 585-86-4 493591
16
Adalimumab Approved Phase 4 331731-18-1 16219006
17
Tofacitinib Approved, Investigational Phase 4 477600-75-2
18
Cabergoline Approved Phase 4 81409-90-7 54746